2022 Neuroimaging Reading List, Learning Objectives, and CME

Reading List

Please click below to access the 2022 Neuroimaging reading list.

2022 Neuroimaging Reading List »

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

Upon completion of this UCNS C-cert activity, participants will be able to:
  • Identify data on appropriate use of neuroimaging in patients in pregnancy and lactation
  • Describe updated recommendations on clinically relevant neuroimaging to monitor multiple sclerosis
  • Recognize/identify imaging findings of current viral infections in adults and children
  • Apply imaging findings from recent stroke trials, including imaging features that predict hemorrhage
  • Identify key features that distinguish normal pressure hydrocephalus and predict clinical outcomes

Core Competencies

This UCNS C-cert activity covers the following core competency:
  • Medical Knowledge

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within three weeks of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry & Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved the program as a part of a comprehensive self-assessment (SA) program, which is mandates by the American Board of Medical Specialties as a necessary component of maintenance of certification. The number of ABPN SA credits granted will equal the number of CME hours claimed for the activity. 


The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy

2022 C-cert Activity Planner Disclosures
All relevant financial relationships have been mitigated.

Neuroimaging Certification Examination Committee Contributors

Jerome J. Graber, MD, MPH, Chair, Alvord Brain Tumor Center
Disclosures: Receives personal compensation to serve as a Social Media Ambassador for the American Society of Neuroimaging and the Journal of Neuroimaging (Wiley). Received personal compensation for participating in market research from Guidepoint and M3 Global. Voluntarily serves on the Editorial Boards of Neuro-oncology: Practice (Oxford) and the Journal of Pain and Symptom Management (American Association of Hospice and Palliative Medicine), as well as on the question writing committee for the Question of the Day app from AAN. 

Jon Y. Choi, MD, PhD, Vice Chair, Walter Reed National Military Medical Center
Disclosures: Nothing to disclose.

Carmel Armon, MD, MHS, Shamir (Assaf Harofeh) Medical Center, Israel 
Disclosures: Nothing to disclose.

Alireza Faridar, MD, Houston Methodist Hospital
Disclosures: Nothing to disclose.

Nazar Haidri, MD
Disclosures: Nothing to disclose.

Mohammad Obadah Nakawah, MD, Houston Methodist Neurological Institute 
Disclosures: Nothing to disclose.

Gustavo Rodriguez, MD, Texas Tech Physicians of El Paso
Disclosures: Nothing to disclose.

Catherine A. Weymann-McKinney, MD, Lake Norman Neurology Hickory – Piedmont Healthcare
Disclosures: Nothing to disclose.

Jennifer Williams McVige, MD, Dent Neurologic Institute
Disclosures: Received compensation for role as speaker for Allergan/AbbVie, Amgen, Avanir, Biohaven, Eli Lilly, Teva, Neurelis, and Theranica; research funding received from Aeon, Allergan/ AbbVie, Amgen/ Novartis, Biohaven, Currax, Eli Lilly and Company, Lundbeck, Teva, and Theranica. Serves on ABPN exam committee by performing quality control for neurologic images used in item bank.

Gregory Kapinos, MD, MS, HEC-C, NYC Health + Hospitals/Elmhurst
Disclosures: Serves on Neurocritical Care Society review group for the question databank for the ABA Neurocritical Care board examination review.

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326